We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+0.47%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$31.4B
AUM Growth
-$3.29B
(-9.5%)
Cap. Flow
-$3.23B
Cap. Flow
% of AUM
-10.31%
Top 10 Holdings %
Top 10 Hldgs %
14.1%
Holding
3,232
New
197
Increased
1,216
Reduced
1,615
Closed
190
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Aptiv
APTV
|
+$16.8M |
| 2 |
CMCSK
COMCAST CORP SPL A (NEW)
CMCSK
|
+$11.8M |
| 3 |
Hilton Worldwide
HLT
|
+$9.58M |
| 4 |
TFCF
Twenty-First Century Fox, Inc. Class B
TFCF
|
+$7.6M |
| 5 |
WEC Energy
WEC
|
+$6.34M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$215M |
| 2 |
Microsoft
MSFT
|
+$101M |
| 3 |
ExxonMobil
XOM
|
+$83.8M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$72.7M |
| 5 |
Johnson & Johnson
JNJ
|
+$68.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 15.19% |
| 2 | Healthcare | 14.93% |
| 3 | Technology | 14.47% |
| 4 | Industrials | 10.76% |
| 5 | Consumer Discretionary | 9.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Merck
MRK
$324B
| $199M | 0.63% |
3,662,157
-728,745
| -17% | -$40.9M |
|
27
PepsiCo
PEP
$186B
| $198M | 0.63% |
2,119,058
-418,210
| -16% | -$40M |
|
28
Cisco
CSCO
$450B
| $195M | 0.62% |
7,089,830
-1,159,439
| -14% | -$33.3M |
|
29
Oracle
ORCL
$331B
| $186M | 0.59% |
4,604,697
-905,810
| -16% | -$39.3M |
|
30
Visa
V
$677B
| $181M | 0.58% |
2,699,379
-519,047
| -16% | -$35.2M |
|
31
UnitedHealth
UNH
$382B
| $176M | 0.56% |
1,440,623
-191,878
| -12% | -$22.7M |
|
32
CVS Health
CVS
$137B
| $172M | 0.55% |
1,639,490
-242,891
| -13% | -$24.8M |
|
33
Amgen
AMGN
$203B
| $171M | 0.54% |
1,111,329
-171,188
| -13% | -$27.4M |
|
34
AbbVie
ABBV
$458B
| $163M | 0.52% |
2,425,320
-250,511
| -9% | -$16.4M |
|
35
Walmart Inc
WMT
$871B
| $157M | 0.5% |
6,623,823
-1,115,592
| -14% | -$28.4M |
|
36
3M
MMM
$89B
| $152M | 0.49% |
1,181,448
-204,345
| -15% | -$27.4M |
|
37
Philip Morris
PM
$301B
| $152M | 0.48% |
1,896,854
-378,039
| -17% | -$31.1M |
|
38
Qualcomm
QCOM
$176B
| $145M | 0.46% |
2,319,767
-522,266
| -18% | -$35.6M |
|
39
Bristol-Myers Squibb
BMY
$127B
| $145M | 0.46% |
2,173,716
-327,639
| -13% | -$21.6M |
|
40
SLB Ltd
SLB
$77.8B
| $142M | 0.45% |
1,642,603
-329,022
| -17% | -$29.7M |
|
|
AGN
41
DELISTED
Allergan plc
AGN
| $141M | 0.45% |
465,114
-96,883
| -17% | -$28.9M |
|
42
Medtronic
MDT
$107B
| $140M | 0.45% |
1,892,402
-386,604
| -17% | -$29.5M |
|
43
Biogen
BIIB
$29.9B
| $135M | 0.43% |
334,433
-56,632
| -14% | -$22.7M |
|
44
McDonald's
MCD
$188B
| $134M | 0.43% |
1,404,403
-254,399
| -15% | -$24.6M |
|
45
Mastercard
MA
$477B
| $132M | 0.42% |
1,415,634
-269,352
| -16% | -$24.7M |
|
|
CELG
46
DELISTED
Celgene Corp
CELG
| $128M | 0.41% |
1,104,995
-199,638
| -15% | -$22.8M |
|
47
Boeing
BA
$165B
| $123M | 0.39% |
884,902
-196,240
| -18% | -$28.6M |
|
48
Union Pacific
UNP
$183B
| $120M | 0.38% |
1,255,146
-252,775
| -17% | -$26.4M |
|
49
RTX Corp
RTX
$287B
| $118M | 0.38% |
1,694,715
-335,242
| -17% | -$24.6M |
|
50
Goldman Sachs
GS
$313B
| $117M | 0.37% |
558,421
-104,843
| -16% | -$21.4M |
|
Similar funds
VAM
RhumbLine Advisers's Q2 2015 Portfolio in Review
As of Q2 2015, RhumbLine Advisers held 3,232 positions worth $31.4B, down 9.5% from $34.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
RhumbLine Advisers withdrew a net $3.23B in Q2 2015, closing 190 positions and reducing 1,615 holdings. Its most notable exit was LORILLARD INC COM STK, an estimated $34M position sold in full.
By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 15% a quarter earlier, followed by Healthcare and Technology.
Against the trend, RhumbLine Advisers opened a new position in COMCAST CORP SPL A (NEW) worth $11.8M.
- RhumbLine Advisers's largest Q2 2015 buy was COMCAST CORP SPL A (NEW): 197,055 shares worth $11.8M.
- RhumbLine Advisers added most to Aptiv in Q2 2015, an estimated $16.8M increase.
- RhumbLine Advisers's biggest Q2 2015 reduction was Apple, cutting an estimated $215M.
- RhumbLine Advisers fully exited LORILLARD INC COM STK in Q2 2015, selling an estimated $34M.
- RhumbLine Advisers's ten largest holdings make up 14% of its $31.4B portfolio in Q2 2015.
- RhumbLine Advisers opened 197 new positions and closed 190 in Q2 2015.
- RhumbLine Advisers's portfolio value fell 9.5% quarter-over-quarter to $31.4B.
Based on RhumbLine Advisers's 13F filing for Q2 2015, filed 4 Aug 2015.